KRT19

(redirected from cytokeratin-19)

KRT19

A gene on chromosome 17q21.2 that encodes the smallest of all type-I keratin proteins, which is expressed in the periderm, the transiently superficial layer that surrounds the developing epidermis.
References in periodicals archive ?
Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.
Cytokeratin-19, high molecular weight cytokeratin, HBME-1, neuroendocrine markers and calcitonin are usually negative in HTT.
Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential.
7~294) Sil-2R (122~496) Hb: Hemoglobin; WBC: white blood cell (count); PLT: Platelet; CRP: C-reactive protein; AST: aspartate aminotransferase; ALT: alanine aminotransferase; Ca: calcium; HTLV-1: Human T-cell Leukemia Virus Type 1; lgG: Immunoglobulin G; IgA: Immunoglobulin A; IgM: immunoglobulin M; IgE: immunoglobulin E; RF: rheumatoid factor; CEA: carcinoem-bryonic antigen; KL-6: Sialylated carbohydrate antigen KL-6; CYFRA: cytokeratin-19 fragments; HCV RNA: hepatitis C virus ribonucleic acid; ACE: angiotensin-converting enzyme; Sil-2R: soluble interleukin-2 receptor; [beta]-D-glucan, Beta-Glucan; ANA: antinuclear antibody.
Background: As the clinical value of cytokeratin-19 (CK19) and thymidine kinase-1 (TK1) in advanced gastrointestinal cancer remains controversial, we investigated their expression and clinical significance in this disease.
Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients.
18) HWJMSCs population has been found to express the early hepatic markers, such as albumin, alpha-fetoprotein (AFP), cytokeratin-19 (CK-19), some mid- and late- hepatic markers, including CK18 and glucose 6-phosphatase (G6P), (19,20) as well as a low level of hematopoietic markers, such as c-kit and phosphoenolpyruvate carboxykinase (PEPCK).
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.
Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19.
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.